Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors characterized by aggressive behavior, high risk of distant recurrence, and poor survival. Chemotherapy is still the main therapeutic approach for this subgroup of patients, therefore, progress in the treatment of TNBC remains an...

Full description

Bibliographic Details
Main Authors: Stefania Cocco, Michela Piezzo, Alessandra Calabrese, Daniela Cianniello, Roberta Caputo, Vincenzo Di Lauro, Giuseppina Fusco, Germira di Gioia, Marina Licenziato, Michelino de Laurentiis
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
TNBC
<i>BRCA1/2</i>
HRR
PDL1
TILs
<i>PI3KCA</i>
Online Access:https://www.mdpi.com/1422-0067/21/13/4579

Internet

https://www.mdpi.com/1422-0067/21/13/4579

Similar Items